Early intensification therapy in high-risk childhood acute lymphocytic leukemia: lack of benefit from high-dose methotrexate.

Standard

Early intensification therapy in high-risk childhood acute lymphocytic leukemia: lack of benefit from high-dose methotrexate. / Janka-Schaub, Gritta; Winkler, K; Juergens, H; Goebel, U.

In: Haematol Blood Transfus, Vol. 30, 1987, p. 456-460.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{173fd2d0f34a4a14a41080afc57518e7,
title = "Early intensification therapy in high-risk childhood acute lymphocytic leukemia: lack of benefit from high-dose methotrexate.",
author = "Gritta Janka-Schaub and K Winkler and H Juergens and U Goebel",
year = "1987",
language = "Deutsch",
volume = "30",
pages = "456--460",
journal = "BLOOD TRANSFUS-ITALY",
issn = "1723-2007",
publisher = "SIMTI SrL",

}

RIS

TY - JOUR

T1 - Early intensification therapy in high-risk childhood acute lymphocytic leukemia: lack of benefit from high-dose methotrexate.

AU - Janka-Schaub, Gritta

AU - Winkler, K

AU - Juergens, H

AU - Goebel, U

PY - 1987

Y1 - 1987

M3 - SCORING: Zeitschriftenaufsatz

VL - 30

SP - 456

EP - 460

JO - BLOOD TRANSFUS-ITALY

JF - BLOOD TRANSFUS-ITALY

SN - 1723-2007

ER -